SHARMEH Intrinsic Value
SHARMEH • Healthcare Services
Current Stock Price
₹100.00
Primary Intrinsic Value
₹43.20
Market Cap
₹40.0 Cr
-50.0%
Downside
Median Value
₹50.00
Value Range
₹31 - ₹238
Assessment
Trading Above Calculated Value
Safety Margin
-100.0%
SHARMEH Valuation Methods Summary
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹43.20 | ₹34.56 - ₹51.84 | -56.8% | EPS: ₹3.60, Sector P/E: 12x |
| Book Value Method | asset | ₹32.50 | ₹29.25 - ₹35.75 | -67.5% | Book Value/Share: ₹32.50, P/B: 1.0x |
| Revenue Multiple Method | revenue | ₹70.00 | ₹63.00 - ₹77.00 | -30.0% | Revenue/Share: ₹87.50, P/S: 0.8x |
| EBITDA Multiple Method | earnings | ₹60.00 | ₹54.00 - ₹66.00 | -40.0% | EBITDA: ₹4.00Cr, EV/EBITDA: 6x |
| Simple DCF (5Y) | dcf | ₹237.71 | ₹190.17 - ₹285.25 | +137.7% | CF Growth: 15.0%, Discount: 15% |
| PEG Ratio Method | growth | ₹42.73 | ₹38.46 - ₹47.00 | -57.3% | EPS Growth: 14.8%, Fair P/E: 11.9x |
| Growth Adjusted P/E | growth | ₹30.96 | ₹27.86 - ₹34.06 | -69.0% | Revenue Growth: 15.0%, Adj P/E: 8.6x |
| ROE Based Valuation | profitability | ₹50.00 | ₹45.00 - ₹55.00 | -50.0% | ROE: 7.7%, P/E Multiple: 10x |
| Graham Defensive Method | conservative | ₹51.31 | ₹46.18 - ₹56.44 | -48.7% | EPS: ₹3.60, BVPS: ₹32.50 |
Method Types:
Earnings
Asset
DCF
Growth
Dividend
Conservative
Valuation Comparison Chart
SHARMEH Intrinsic Value Analysis
What is the intrinsic value of SHARMEH?
Based on our comprehensive analysis using 9 different valuation methods, the estimated intrinsic value of SHARMEH (SHARMEH) is ₹50.00 (median value). With the current market price of ₹100.00, this represents a -50.0% variance from our estimated fair value.
The valuation range spans from ₹30.96 to ₹237.71, indicating ₹30.96 - ₹237.71.
Is SHARMEH undervalued or overvalued?
Based on our multi-method analysis, SHARMEH (SHARMEH) appears to be trading above calculated value by approximately 50.0%.
Financial Health Analysis
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 15.00 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Return on Equity | 7.7% | Industry Standard: 15%+ | Below 10% | Measures shareholder return efficiency |
| Operating Margin | 10.0% | Industry Standard: 20%+ | Above 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 1.25x | Industry Standard: 1.0x+ | Above 1.0x | Measures asset utilization efficiency |
Related Pages for SHARMEH
Additional stock information and data for SHARMEH
Cash Flow Quality Analysis
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹7 Cr | ₹6 Cr | Positive Free Cash Flow | 8/10 |
| March 2024 | ₹-1 Cr | ₹-1 Cr | Negative Cash Flow | 3/10 |
| March 2023 | ₹1 Cr | ₹-1 Cr | Positive Operating Cash Flow | 6/10 |
| March 2022 | ₹2 Cr | ₹1 Cr | Positive Free Cash Flow | 7/10 |
| March 2021 | ₹1 Cr | ₹1 Cr | Positive Free Cash Flow | 8/10 |